Central nervous system reactions to histamine-2 receptor blockers
- PMID: 1674198
- DOI: 10.7326/0003-4819-114-12-1027
Central nervous system reactions to histamine-2 receptor blockers
Abstract
Purpose: To review the incidence, risk factors, pharmacology, and management of central nervous system reactions to histamine-2 receptor (H2) blockers.
Data identification: English-language articles were identified through a search of the MEDLINE and Current Contents data-bases. Bibliographies of retrieved articles were examined for relevant articles. Case reports submitted to the Food and Drug Administration through 19 September 1989 were obtained.
Study selection: Studies on the association between central nervous system toxicity (psychosis, agitation, hallucinations, delirium, mental status changes, disorientation, confusion, irritability, obtundation, or hostility) and H2 blockers were analyzed.
Data extraction: All data on the incidence of and potential predisposing factors for central nervous system reactions to H2 blockers were analyzed. Limitations of the data are discussed.
Results of data synthesis: Central nervous system toxicities have been associated with all H2 blockers. These reactions generally occur during the first 2 weeks of therapy and resolve within 3 days of drug withdrawal. The estimated incidence of central nervous system reactions is 0.2% or less in outpatients and 1.6% to 80% in hospitalized patients. Cimetidine is most frequently associated with these reactions; however, no clear evidence exists that one H2 blocker is more likely than another to cause a reaction. Risk factors for central nervous system reactions have been proposed, but only advanced age has some, albeit limited, data to support it as a risk factor. Studies have only infrequently established causality and there have been difficulties in establishing risk factors for an relative incidences of a phenomenon that occurs infrequently in outpatients and that can be multifactorial in origin.
Conclusions: All H2 blockers are associated with central nervous system reactions. There is no clear evidence of a higher rate of reactions with one H2 blocker compared with another.
Comment in
-
Histamine-2 receptor blockers and delirium.Ann Intern Med. 1991 Oct 15;115(8):658. doi: 10.7326/0003-4819-115-8-658_1. Ann Intern Med. 1991. PMID: 1679983 No abstract available.
Similar articles
-
Adverse reactions and interactions with H2-receptor antagonists.Med Toxicol. 1986 May-Jun;1(3):192-216. doi: 10.1007/BF03259837. Med Toxicol. 1986. PMID: 2878343 Review.
-
Safety profile of H2-receptor antagonists: current status of famotidine.J Int Med Res. 1989;17 Suppl 1:48A-53A. J Int Med Res. 1989. PMID: 2566543
-
Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status.Pharmacol Toxicol. 1991 Oct;69(4):253-8. doi: 10.1111/bcpt.1991.69.4.253. Pharmacol Toxicol. 1991. PMID: 1683484
-
Safety of histamine-2 receptor blockers in hospitalized VLBW infants.Early Hum Dev. 2016 Aug;99:27-30. doi: 10.1016/j.earlhumdev.2016.05.010. Epub 2016 Jul 4. Early Hum Dev. 2016. PMID: 27390109 Free PMC article.
-
Suicidal Ideation.2022 May 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. 2022 May 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 33351435 Free Books & Documents.
Cited by 20 articles
-
Management of Medication-Induced Psychiatric Disorders.Indian J Psychiatry. 2022 Mar;64(Suppl 2):S281-S291. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_21_22. Epub 2022 Mar 23. Indian J Psychiatry. 2022. PMID: 35602361 Free PMC article. No abstract available.
-
Machine Learning-Based Prediction of Drug-Drug Interactions for Histamine Antagonist Using Hybrid Chemical Features.Cells. 2021 Nov 9;10(11):3092. doi: 10.3390/cells10113092. Cells. 2021. PMID: 34831315 Free PMC article.
-
Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database.J Alzheimers Dis. 2021;82(3):1333-1344. doi: 10.3233/JAD-210524. J Alzheimers Dis. 2021. PMID: 34151816 Free PMC article.
-
The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication.Sci Rep. 2021 Mar 8;11(1):5433. doi: 10.1038/s41598-021-84782-w. Sci Rep. 2021. PMID: 33686143 Free PMC article.
-
Histamine receptors and COVID-19.Inflamm Res. 2021 Jan;70(1):67-75. doi: 10.1007/s00011-020-01422-1. Epub 2020 Nov 18. Inflamm Res. 2021. PMID: 33206207 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials